Skip to content

Registry and Biorepository for IBD in Central Texas

Registry and Biorepository for the Study of Inflammatory Bowel Diseases in Central Texas

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04617184
Enrollment
1000
Registered
2020-11-05
Start date
2021-06-01
Completion date
2030-12-31
Last updated
2021-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn Disease, Inflammatory Bowel Diseases, Ulcerative Colitis

Brief summary

This is a prospective, non-interventional registry and biorepository for patients with IBD. Longitudinal follow-up data is collected from both patients and their treating gastroenterologist during routine clinical encounters. The biorepository will consist of prospective collection of blood samples, tissue samples, and fecal samples for research purposes, while the participants are undergoing a clinically-indicated procedure (i.e. venipuncture for routine tests, IV catheter placement, and/or endoscopy). Participants may choose to provide any or all of the aforementioned information and/or samples.

Interventions

OTHERNO INTERVENTION

THERE IS NO INTERVENTION TO THIS TRIAL. THIS IS A REGISTRY

Sponsors

University of Texas at Austin
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Male or female, age 18 years or older * Willing and able to provide written consent for participation in the registry and biorepository * Patients with known or suspected inflammatory bowel disease

Exclusion criteria

* Patient is unable to comprehend and/or cooperate with study activities * Patient is too ill to provide consent * Coagulopathy that precludes safe biopsy of the bowel * Comorbidity that precludes safe participation in endoscopic procedures

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with inflammatory bowel disease10 YEARSNumber of patients with Crohns, ulcerative colitis, and IBD undetermined

Countries

United States

Contacts

Primary ContactBenjamin Chebaa, BA
benjamin.chebaa@austin.utexas.edu5124955641

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026